MAPT and Alzheimer disease: Many large genome-wide association studies (GWAS) have been successful in finding loci that affect AD biomarkers such as Aβ42, tau, and ptau. In a series of papers, Hohman et al. [2–4] performed a variety of analyses that screened for loci that modify the relationship between various AD-related risk factors.